ANR Volume Alert - ANR 2.91 Alpha Natural Resources $ANR

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
ANR Volume Alert - ANR 2.91 Alpha Natural Resources $ANR Hit a high of 2.94 Currently 11/07/14 Last price 2.91 +0.39 +15.48% With a day low of 2.55 and a current volume of 21,959,301.

ANR Alpha Natural Resources Recent Headline News

Most active New York Stock Exchange-traded stocks
AP - Fri Nov 07, 5:08PM CST
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:
KMI: 38.75 (+0.22), F: 14.17 (-0.02), GE: 26.41 (+0.05), RF: 10.16 (-0.07), ABX.TO: 13.79 (+0.82), K.TO: 2.84 (+0.30), ABX: 12.16 (+0.82), BAC: 17.36 (unch), ANR: 2.91 (+0.39), GNW: 8.41 (-0.25), YRI.TO: 4.47 (+0.44), KGC: 2.50 (+0.29), S: 4.72 (+0.03), TWTR: 40.31 (-0.53), AUY: 3.92 (+0.38)

Humana and Salix are big market movers
AP - Fri Nov 07, 3:34PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
WFM: 46.81 (+1.96), TSLA: 240.20 (-1.02), FSLR: 50.29 (-6.12), RIG: 29.71 (-0.21), WWWW: 15.40 (+0.68), GNRC: 40.86 (-1.23), SLXP: 91.47 (-47.08), BRKR: 17.91 (-2.98), KATE: 30.37 (-0.59), GNW: 8.41 (-0.25), SHLD: 42.81 (+10.14), ANR: 2.91 (+0.39), MCO: 98.95 (-0.04), HUM: 130.58 (-9.29)

Alpha Natural Resources (ANR) Stock Spiking Today Off Election Results
at The Street - Thu Nov 06, 2:09PM CST
Alpha Natural Resources (ANR) stock is rising with the coal sector following the outcome of Tuesday's election.
ANR: 2.91 (+0.39)

Arch Coal (ACI) Stock Climbing Today After Election Outcome
at The Street - Thu Nov 06, 12:16PM CST
Arch Coal (ACI) stock is up as coal stocks rise following Tuesday's election results in which Republican's took control of Congress.
BTU: 11.64 (+0.80), ACI: 2.86 (+0.44), CLD: 13.60 (+0.43), ANR: 2.91 (+0.39)

Alpha Natural Resources (ANR) Stock Higher Today on Improved Coal Use Prospects
at The Street - Wed Nov 05, 2:39PM CST
Shares of Alpha Natural Resources (ANR) are up after yesterday's Congressional elections, which may improve the prospects of increased coal usage.
ANR: 2.91 (+0.39)

GOP Win Lifts TransCanada, Medical Device, Coal Stocks
at Investor's Business Daily - Wed Nov 05, 1:35PM CST
Prospects for approval of the Keystone XL pipeline, and for Calgary-based pipeline operator TransCanada (TRP), brightened after the GOP gained control of the Senate Tuesday. The power shift in Washington is also expected to benefit medical device...
BSX: 13.24 (-0.12), BTU: 11.64 (+0.80), MDT: 68.10 (-0.64), TRP: 49.40 (+0.18), STJ: 64.76 (-1.28), ANR: 2.91 (+0.39)

Republicans Grab Senate: Which Stocks Will Fare Well? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:19AM CST
The Republican win will certainly bolster stocks and give investors more chances to earn.
GD: 140.14 (-1.42), LMT: 186.15 (-3.73), MDT: 68.10 (-0.64), QDEL: 27.87 (-0.80), XOM: 96.59 (+0.33), CLF: 11.17 (+0.63), BA: 124.45 (-0.13), NUVA: 41.75 (-0.18), ANR: 2.91 (+0.39), BSX: 13.24 (-0.12), VLO: 50.72 (+0.48), BTU: 11.64 (+0.80), ABAX: 51.63 (-2.21), IMO: 47.63 (+0.74), ACI: 2.86 (+0.44)

3 Best Coal Dividend Stocks for a Market Crash
Reuben Brewer, The Motley Fool - Motley Fool - Sat Nov 01, 11:39AM CDT
According to the U.S. Energy Information Administration, or EIA, coal is expected to be a major part of the U.S. power grid for decades to come. That's at odds with the environmentalist's view that renewable power will displace it. This dichotomy...
ARLP: 47.56 (+0.47), BTU: 11.64 (+0.80), ACI: 2.86 (+0.44), ANR: 2.91 (+0.39)

Peabody Energy’s Prospects Darkening on Outlook for Coal
at The Street - Thu Oct 30, 1:20PM CDT
The world's largest coal producer is optimistic. analysts less so.
BTU: 11.64 (+0.80), ACI: 2.86 (+0.44), WLT: 3.19 (+0.45), ANR: 2.91 (+0.39)

Alpha Natural Resources 3Q results top Street
AP - Thu Oct 30, 11:58AM CDT
BRISTOL, Va. (AP) — Alpha Natural Resources' third-quarter loss narrowed, helped by reduced costs.
ANR: 2.91 (+0.39)

Alpha Natural Resources (ANR) Stock Drops as More Coal Production Cuts Loom
at The Street - Thu Oct 30, 11:31AM CDT
Shares of Alpha Natural Resources (ANR) were down Thursday after the largest U.S. producer of metallurgical coal said more production cuts are probable because the market is still oversupplied.
ANR: 2.91 (+0.39)

Alpha Natural Resources Posts Narrower-than-Expected Q3 Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 10:24AM CDT
Alpha Natural Resources' (ANR) loss of 53 cents per share for the third quarter of 2014 was narrower than the Zacks Consensus Estimate of a loss of 71 cents.
BTU: 11.64 (+0.80), CNX: 39.98 (+0.64), ACI: 2.86 (+0.44), ANR: 2.91 (+0.39)

Alpha Natural Resources Announces Results for Third Quarter 2014
PR Newswire - Thu Oct 30, 7:05AM CDT
Alpha Natural Resources, Inc. (NYSE: ANR), a leading U.S. coal producer, reported a third quarter 2014 net loss of $185 million or $0.84 per diluted share, compared with a net loss of $458 million or $2.07 per diluted share in the third quarter of 2013. Excluding the items described in "Reconciliation of Adjusted Net Loss to Net Loss," the third quarter 2014 adjusted net loss was $118 million or $0.53 per diluted share compared with adjusted net loss of $134 million or $0.61 per diluted share in the third quarter of 2013.
RICE: 29.18 (+1.52), ANR: 2.91 (+0.39)

SunCoke Energy (SXC) Beats Q3 Earnings Estimates, Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 10:20AM CDT
SunCoke Energy Inc.'s (SXC) third-quarter 2014 earnings from continuing operations beat the Zacks Consensus Estimate.
ACI: 2.86 (+0.44), SXC: 23.67 (+0.11), FELP: 19.00 (+0.51), ANR: 2.91 (+0.39)

Alpha Natural Resources (ANR) Showing Signs Of A Dead Cat Bounce Today
at The Street - Mon Oct 20, 8:47AM CDT
Trade-Ideas LLC identified Alpha Natural Resources (ANR) as a "dead cat bounce" (down big yesterday but up big today) candidate
ANR: 2.91 (+0.39)

Troubles Continue For Repros Therapeutics
at The Street - Fri Oct 17, 12:02PM CDT
Corinthian Colleges Inc (NASDAQ:COCO), dELiA*s, Inc. (NASDAQ LIA) and BioFuel Energy Corp. (NASDAQ:BIOF) are on the upswing this Friday. In the red are Repros Therapeutics Inc (NASDAQ:RPRX), KiOR I...
DLIA: 0.13 (unch), RPRX: 10.12 (+3.67), COCO: 0.17 (+0.01), ANR: 2.91 (+0.39), BIOF: 7.28 (+0.01)

Oil, Gas and Consumable Fuels Stocks Technical Analysis - Alpha Natural Resources, Arch Coal, Solazyme, Royal Dutch Shell, and YPF S.A.
PR Newswire - Fri Oct 17, 7:45AM CDT
Investor-Edge has initiated coverage on the following equities: Alpha Natural Resources Inc. (NYSE: ANR), Arch Coal Inc. (NYSE: ACI), Solazyme Inc. (NASDAQ: SZYM), Royal Dutch Shell PLC (NYSE: RDS-A), and YPF S.A. (NYSE: YPF). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Thursday, October 16, 2014, the NASDAQ Composite ended at 4,217.39, up 0.05%, the Dow Jones Industrial Average edged 0.15% lower, to finish the day at 16,117.24, and the S&P 500 closed at 1,862.76, up 0.01%. During the session, five out of ten sectors ended in positive. The S&P 500 Energy Sector Index ended the day at 601.39, up 1.69%, with the index also advancing 0.87% in the previous three trading sessions. Register for your complimentary reports on these five stocks at:
ACI: 2.86 (+0.44), YPF: 34.09 (+0.15), ANR: 2.91 (+0.39), SZYM: 3.63 (+0.49)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 269

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
China's 15th Plan: Key Moves in the Capital Markets

Updated Category News Views 127

Riding the Waves of Reform in China The winds of change are blowing through China's capital markets, and Guosen Securities is putting a stake in the ground with bold priorities for the 15th Five-Year Plan. As far as I'm concerned, the headlines here are thick with implications for anyone eyeing a piece of China's economic pie from 2026–2030. The Pillars of Stability and...

Continue Reading
CStone's CS2009: A Leap in Cancer Treatment Validated

Updated Category News Views 59

CStone's Game-Changer: CS2009 in the Spotlight CStone Pharmaceuticals just pulled a rabbit out of a hat at the ESMO 2026 Congress, showcasing the clinical might of their CS2009. This ain't just another hype train, folks. We're talking about a trispecific antibody targeting PD-1, VEGF, and CTLA-4. With data rolled out from over 300 patients, this compound promises a...

Continue Reading
NOTHING NINE's Global Ambitions: Paris Show's Impact

Updated Category News Views 83

Paris: Stage or Launchpad? You’d think walking that catwalk in Paris is the holy grail—fashion's own illustrious red carpet. But when you're Chloe, founder of NOTHING NINE, the real hustle kicks off once the lights dim. On 29th September 2026, this designer brand strutted its stuff at one of the grandest venues, Les Invalides, part of the prestigious Paris Fashion...

Continue Reading
Ambient AI Shows Promise for Boosting Cancer Care Efficiency

Updated Category News Views 13

Study Points to Ambient AI's Promise in Oncology Some days, the world of cancer care is a real beast to tackle. But today, we've got a glimpse into how technology, and specifically ambient AI, might just help slay some of the burdens that these healthcare warriors face daily. The Florida Cancer Specialists & Research Institute (FCS) joined hands to dive into how this tech...

Continue Reading
Superteam Wheels Rides Into Spain with RACEIT Deal

Updated Category News Views 63

Rolling Out the Red Carpet for Spanish Cyclists Think of it as the pedal-powered bridge from wherever Superteam Wheels calls home to the sunny streets of Spain. If you're in the cycling game, this new partnership between Superteam Wheels and COMERTECH RACEIT, S.L., better known as RACEIT, is drawing a line in the sand—or perhaps on the asphalt—across Europe. Starting...

Continue Reading
Zinzino Eyes European Market With New Botanical Line

Updated Category News Views 98

Zinzino's Strategic Play in Europe's Wellness Market There's a new player on the European wellness block, and it's Zinzino's latest concoction of fermented botanical supplements. This isn't just your run-of-the-mill vitamin shop stock; we're talking about a lineup crafted for distinct parts of the day, reflecting an evolving consumer trend. People are looking for tailored...

Continue Reading
HCLTech Partners with Rapidus on Semiconductor Future

Updated Category News Views 81

Making Sense of the HCLTech and Rapidus Collaboration When you're talking about the world of semiconductors, no two words get tossed around more than innovation and speed. Now, with the recent partnership between HCLTech and Rapidus, those words are bound to echo from India to Japan and beyond. We have HCLTech, a stalwart of global technology, teaming up with Rapidus, a...

Continue Reading
ASICS and University of Michigan Launch Innovation Lab

Updated Category News Views 88

Running Innovation Gets a Boost in Ann Arbor On a crisp fall day up in Ann Arbor, ASICS and the University of Michigan have decided it's high time to shake up the world of running product R&D. These two powerhouses just launched the ASICSx Michigan Sport Innovation Center (AMSI), an academic-industry research lab. It's like they're mixing college smarts with business...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 412

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

DXC Technology to Announce Q3 Fiscal 2026 Earnings Soon

Updated Category News Views 159

DXC Technology Announces Upcoming Q3 Fiscal 2026 Earnings DXC Technology (NYSE: DXC), a prominent leader in enterprise technology and innovation, has set a date for the release of its financial results for the third quarter of fiscal 2026. The earnings report will be published on a Thursday, after the market closes, providing stakeholders with insights into the company's...

Continue Reading
Jim Cramer Highlights Mettler-Toledo as a Buy Amid Market Woes

Updated Category News Views 188

Jim Cramer Recommends Mettler-Toledo International Inc. On a recent episode of CNBC's popular program, Jim Cramer advised investors to consider buying shares of Mettler-Toledo International Inc. (NYSE: MTD). Cramer's endorsement came after the company reported impressive quarterly results, showcasing strong financial health. Strong Earnings Report from Mettler-Toledo...

Continue Reading
Strategic Alliance Between Vireo and Curio Enhances Growth Opportunities

Updated Category News Views 110

Strategic Partnership Announced Leading cannabis companies Vireo Growth Inc. and Curio Wellness have forged a partnership aimed at leveraging shared resources to tap into the burgeoning cannabis market. This collaboration marks an exciting new chapter for both companies as they work to introduce innovative health and wellness products to consumers. Vireo Growth Inc.: A...

Continue Reading
Anoto Group Reports Second Quarter Results 2024

Updated Category News Views 137

Overview of the Interim Report for 2024 The interim report covering January to June 2024 provides important insights into Anoto Group AB's operations and financial health. Anoto Group continues to be a leader in technology, particularly in optical recognition and digital writing. This report emphasizes key financial metrics and the company's strategic initiatives in a...

Continue Reading
AAOS: Orthobiologics' Future Anchored in Solid Science

Updated Category News Views 9

The Challenge of Orthobiologics: Hype vs. Science Amid the buzz around orthobiologics, it's high time folks face reality: enthusiasm doesn't equal evidence. Dr. Jason Dragoo, the symposium co-chair, hit the nail right on the head—the medical community's chief duty is to sift the wheat from the chaff when it comes to flashy new treatments that lack scientific backing....

Continue Reading